Enhanced nitrosative stress during Trypanosoma cruzi infection causes nitrotyrosine modification of host proteins: Implications in Chagas' disease

American Journal of Pathology

Volumn 173, Issue 3, 2008, Pages 728-740

  Dhiman, Monisha ^a   Nakayasu, Ernesto Satoshi ^c   Madaiah, Yashoda Hosakote ^b   Reynolds, Brobey K ^b   Wen, Jian Jun ^a   Almeida, Igor Correia ^c   Garg, Nisha Jain ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c UNIVERSITY OF TEXAS AT EL PASO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ALCOHOL; ALPHA ACTIN; APOLIPOPROTEIN; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; CONNECTIN; IMMUNOGLOBULIN; MYELOPEROXIDASE; NITRATE; NITRIC OXIDE; NITRITE; PEPTIDE; PROTEIN CARBONYL; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CHAGAS DISEASE; CONTROLLED STUDY; DATA BASE; DISEASE MODEL; ENZYME ACTIVITY; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NITROSATIVE STRESS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; SEQUENCE HOMOLOGY; SPRAGUE DAWLEY RAT; TANDEM MASS SPECTROMETRY; TRYPANOSOMA CRUZI; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 51349110109     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080047     Document Type: Article

References (56)

1. Higuchi MD, Benvenuti LA, Martins Reis M, Metzger M: Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 2003, 60:96-107
2. Rossi MA, Ramos SG, Bestetti RB: Chagas' heart disease: clinical-pathological correlation. Front Biosci 2003, 8:e94-e109
3. Leon JS, Engman DM: The significance of autoimmunity in the pathogenesis of Chagas heart disease. Front Biosci 2003, 8:e315-322
4. Tostes S Jr, Bertulucci Rocha-Rodrigues D, de Araujo Pereira G, Rodrigues V Jr: Myocardiocyte apoptosis in heart failure in chronic Chagas' disease. Int J Cardiol 2005, 99:233-237
5. Zacks MA, Wen J-J, Vyatkina G, Bhatia V, Garg N: An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress. Ann Acad Bras Cienc 2005, 77:695-715
6. Schirmer RH, Schollhammer T, Eisenbrand G, Krauth-Siegel RL: Oxidative stress as a defense mechanism against parasitic infections. Free Radic Res Commun 1987, 3:3-12
7. Cardoni RL, Antunez MI, Morales C, Nantes IR: Release of reactive oxygen species by phagocytic cells in response to live parasites in mice infected with Trypanosoma cruzi. Am J Trop Med Hyg 1997, 56:329-334
8. Cross AR, Yarchover JL, Curnutte JT: The superoxide-generating system of human neutrophils possesses a novel diaphorase activity. Evidence for distinct regulation of electron flow within NADPH oxidase by p67-phox and p47-phox. J Biol Chem 1994, 269:21448-21454
9. Winterbourn CC, Vissers MC, Kettle AJ: Myeloperoxidase. Curr Opin Hematol 2000, 7:53-58
10. Candeias LP, Patel KB, Stratford MR, Wardman P: Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorous acid. FEBS Lett 1993, 333:151-153
11. Vespa GN, Cunha FQ, Silva JS: Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun 1994, 62:5177-5182
12. Piacenza LPG, Alvarez MN, Kelly JM, Wilkinson SR, Radi R: Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage- and endogenously-derived peroxynitrite. Biochem J 2008, 410(2):359-368
13. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996, 271:C1424-1437
14. Wen J-J, Yachelini PC, Sembaj A, Manzur RE, Garg N: Increased oxidative stress is correlated with mitochondrial dysfunction in chagasic patients. Free Radic Biol Med 2006, 41:270-276
15. de Oliveira TB, Pedrosa RC, Filho DW: Oxidative stress in chronic cardiopathy associated with Chagas disease. Int J Cardiol 2007, 116:357-363
16. Perez-Fuentes R, Guegan JF, Barnabe C, Lopez-Colombo A, Salgado-Rosas H, Torres-Rasgado E, Briones B, Romero-Diaz M, Ramos-Jimenez J, Sanchez-Guillen Mdel C: Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals. Int J Parasitol 2003, 33:293-299
17. Wen J-J, Vyatkina G, Garg N: Oxidative damage during chagasic cardiomyopathy development: role of mitochondrial oxidant release and inefficient antioxidant defense. Free Radic Biol Med 2004, 37:1821-1833
18. Wen J-J, Bhatia V, Popov VL, Garg NJ: Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas disease. Am J Pathol 2006, 169:1953-1964
19. Macao LB, Filho DW, Pedrosa RC, Pereira A, Backes P, Torres MA, Frode TS: Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease, Int J Cardiol 2007, 123:43-49
20. Alvarez MN, Irigoín F, Peluffo G, Radi R: Macrophage-derived peroxynitrite diffusion and toxicity to Trypanosoma cruzi. Arch Biochem Biophys 2004, 432:222-232
21. Naviliat M, Gualco G, Cayota A, Radi R: Protein 3-nitrotyrosine formation during Trypanosoma cruzi infection in mice. Braz J Med Biol Res 2005, 38:1825-1834
22. Lui CY, Guan ZJ, Eskelson CD: Cardiac function in rats exposed to chronic alcohol and nutritional deficiency involving selenium and vitamin E. J Appl Res 2004, 4:427-438
23. Colantonio DA, Dunkinson C, Bovenkamp DE, Van Eyk JE: Effective removal of albumin from serum. Proteomics 2005, 5:3831-3835
24. Buss IH, Winterbourn CC: Protein carbonyl measurement by ELISA. Methods Mol Biol 2002, 186:123-128
25. Sawa T, Akaike T, Maeda H: Tyrosine nitration by peroxynitrite formed from nitric oxide and superoxide generated by xanthine oxidase. J Biol Chem 2000, 275:32467-32474
26. Kleinbongard P, Rassaf T, Dejam A, Kerber S, Kelm M: Griess method for nitrite measurement of aqueous and protein-containing samples. Methods Enzymol 2002, 359:158-168
27. Vodovotz Y: Modified microassay for serum nitrite and nitrate. Biotechniques 1996, 20:390-394
28. Bradley PP, Priebat DA, Christensen RD, Rothstein G: Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982, 78:206-209
29. Terada LS, Leff JA, Repine JE: Measurement of xanthine oxidase in biological tissues. Methods Enzymol 1990, 186:651-656
30. Buscaglia CA, Campo VA, Di Noia JM, Torrecilhas AC, De Marchi CR, Ferguson MA, Frasch AC, Almeida IC: The surface coat of the mammal-dwelling infective trypomastigote stage of Trypanosoma cruzi is formed by highly diverse immunogenic mucins. J Biol Chem 2004, 279:15860-15869
31. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 1990, 215:403-410
32. Doering TL, Lu T, Werbovetz KA, Gokel GW, Hart GW, Gordon JI, Englund PT: Toxicity of myristic acid analogs toward African trypanosomes. Proc Natl Acad Sci USA 1994, 91:9735-9739
33. Miyagi MSH, Darrow RM, Yan L, West KA, Aulak KS, Stuehr DJ, Hollyfield JG, Organisciak DT, Crabb JW: Evidence that light modulates protein nitration in rat retina. Mol Cell Proteomics 2002, 1:293-303
34. Munoz-Fernandez MA, Fernandez MA, Fresno M: Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunol Lett 1992, 33:35-40
35. Melo RC, Fabrino DL, D'Avila H, Teixeira HC, Ferreira AP: Production of hydrogen peroxide by peripheral blood monocytes and specific macrophages during experimental infection with Trypanosoma cruzi in vivo. Cell Biol Int 2003, 27:853-861
36. Martins GACM, Aliberti JC, Silva JS: Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice. Immunol Lett 1998, 63:113-120
37. Bergeron MOM: Trypanosoma cruzi-mediated IFN-gamma-inducible nitric oxide output in macrophages is regulated by iNOS mRNA stability. J Immunol 2006, 177:6271-6280
38. Uesugi M, Yoshida K, Jasin HE: Inflammatory properties of IgG modified by oxygen radicals and peroxynitrite. J Immunol 2000, 165:6532-6537
39. Margiloff L, Chaplia L, Chow A, Singhal PC, Mattana J: Metal-catalyzed oxidation of immunoglobulin G impairs Fc receptor-mediated binding to macrophages. Free Radic Biol Med 1998, 25:780-785
40. Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Kahan A, Ekindjian OG, Borderie D: Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy. Clin Chim Acta 2006, 372:147-153
41. Zurawa-Janicka D, Renke J, Popadiuk S, Skorko-Glonek J, Szumera M, Plata-Nazar K, Ulko P, Wozniak M, Lipinska B: Preferential immunoglobulin oxidation in children with juvenile idiopathic arthritis. Scand J Rheumatol 2006, 35:193-200
42. Khan F, Siddiqui AA, Ali R: Measurement and significance of 3-nitrotyrosine in systemic lupus erythematosus. Scand J Immunol 2006, 64:507-514
43. Vadseth C, Souza JM, Thomson L, Seagraves A, Nagaswami C, Scheiner T, Torbet J, Vilaire G, Bennett JS, Murciano JC, Muzykantov V, Penn MS, Hazen SL, Weisel JW, Ischiropoulos H: Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. J Biol Chem 2004, 279:8820-8826
44. Gole MD, Souza JM, Choi I, Hertkorn C, Malcolm S, Foust RF, 3rd, Finkel B, Lanken PN, Ischiropoulos H: Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2000, 278:L961-L967
45. Parastatidis ITL, Fries DM, Moore RE, Tohyama J, Fu X, Hazen SL, Heijnen HF, Dennehy MK, Liebler DC, Rader DJ, Ischiropoulos Increased protein nitration burden in the atherosclerotic lesions and plasma of apolipoprotein A-I deficient mice, Circ Res 2007, 101:368-376
46. Lewis GF: Determinants of plasma HDL concentrations and reverse cholesterol transport. Curr Opin Cardiol 2006, 21:345-352
47. Nicholls SJ, Zheng L, Hazen SL: Formation of dysfunctional high-density lipoprotein by myeloperoxidase. Trends Cardiovasc Med 2005, 15:212-219
48. Shao B, Bergt C, Fu X, Green P, Voss JC, Oda MN, Oram JF, Heinecke JW: Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. J Biol Chem 2005, 280:5983-5993
49. Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Hama S, Hough G, Bachini E, Grijalva VR, Wagner AC, Shaposhnik Z, Fogelman AM: The double jeopardy of HDL. Ann Med 2005, 37:173-178
50. Marin-Neto JA, Simoes MV, Ayres-Neto EM, Attab-Santos JL, Gallo L Jr, Amorim DS, Maciel BC: Studies of the coronary circulation in Chagas' heart disease. Sao Paulo Med J 1995, 113:826-834
51. Hyka N, Dayer JM, Modoux C, Kohno T, Edwards CK 3rd, Roux-Lombard P, Burger D: Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 2001, 97:2381-2389
52. Burger D, Dayer JM: High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation? Autoimmun Rev 2002, 1:111-117
53. Van Lenten BJ, Hama SY, de Beer FC, Stafforini DM, McIntyre TM, Prescott SM, La Du BN, Fogelman AM, Navab M: Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 1995, 96:2758-2767
54. Brener Z, Gazzinelli RT: Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol 1997, 114:103-110
55. Daemen MA, Heemskerk VH, van't Veer C, Denecker G, Wolfs TG, Vandenabeele P, Buurman WA: Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation 2000, 102:1420-1426
56. Hein S, Kostin S, Heling A, Maeno Y, Schaper J: The role of the cytoskeleton in heart failure. Cardiovasc Res 2000, 45:273-278